HIV-HCV Coinfection
Pegylated
Interferon plus Weight-based Ribavirin Produces High Sustained Response Rates
in PRESCO Trial
10/13/06
Effect
of CD4 Percentage on Response to Hepatitis C Therapy
10/13/06
Treatment
of Acute Sexually Transmitted HCV
10/10/06
Hyperlipidemia
Less Common among HIV-HCV Coinfected Patients on HAART
10/10/06
Does
Long-Term Antiretroviral Therapy Promote Liver Fibrosis?
10/06/06
More
Advanced Liver Fibrosis in HIV-HCV Coinfected Patients
10/06/06
Natural
History of HIV-HCV Coinfection in Children
10/06/06 Efficacy
of Pegylated Interferon plus Ribavirin Re-treatment in HIV-HCV Coinfected Patients
10/03/06
Effect
of NRTI-sparing Antiretroviral Regimens on Outcomes of Hepatitis C Treatment
10/03/06
Extent
of Fibrosis Influences NNRTI Levels in HIV-HCV Coinfected Patients
10/03/06
Baseline
Viral Load as a Predictor of Sustained Virological Response in HIV-HCV Coinfected
Patients
9/29/06 Impact
of HCV Coinfection on Mother-to-Child HIV Transmission
9/29/06
|
| 